Committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing & manufacturing innovative therapeutics
One exciting part of Amgen’s drug-discovery program is to identify new immune checkpoints that act as brakes on the immune system and target those checkpoints with innovative drugs, enabling T cells to attack cancer cells. #WeAreBiotech
Sound On: In the final excerpt from the @MilkenInstitute podcast, CEO Bob Bradway discusses actions we've taken during #COVID19 to support staff. You can listen to the full, wide-ranging interview with him here: $AMGN
#Alzheimer ’s is a debilitating, incurable disease estimated to affect more than 44 million people worldwide. RT to show your support for those affected by the disease #AAIC18
About 50% of people diagnosed with #heartfailure in the U.S. die within five years of diagnosis.